Marksans Pharma consolidated net profit rises 15.80% in the September 2024 quarter

Sales rise 20.83% to Rs 641.92 crore

Net profit of Marksans Pharma rose 15.80% to Rs 96.72 crore in the quarter ended September 2024 as against Rs 83.52 crore during the previous quarter ended September 2023. Sales rose 20.83% to Rs 641.92 crore in the quarter ended September 2024 as against Rs 531.24 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	641.92	531.24	21
OPM %	21.14	21.45	-
PBDT	144.11	131.32	10
PBT	124.60	113.77	10
NP	96.72	83.52	16

Powered by Capital Market - Live News